Christine Klipping
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Inhibition of ovulation and pharmacologic mechanism of action of relugolix combination therapy.
Journal: Fertility and sterility
Published: October 26, 2023
Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrel.
Journal: Contraception
Published: August 10, 2021
Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
Journal: Contraception
Published: December 23, 2020
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
Journal: Contraception
Published: October 11, 2020
Ovulation inhibition with a new vaginal ring containing trimegestone.
Journal: Contraception
Published: March 20, 2020
The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg.
Journal: Contraception
Published: September 03, 2019
Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: September 12, 2018
Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
Journal: Human reproduction (Oxford, England)
Published: February 25, 2018
A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Journal: Human reproduction (Oxford, England)
Published: January 30, 2017
Last Updated: 09/26/2026